Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 756

1.

Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients.

van Santen S, Jansen PM, Quint KD, Vermeer MH, Willemze R.

J Cutan Pathol. 2019 Nov 22. doi: 10.1111/cup.13615. [Epub ahead of print]

PMID:
31755567
2.

Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis.

Melchers RC, Willemze R, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Veraart JCJM, Putter H, Jansen PM, Vermeer MH, Quint KD.

J Eur Acad Dermatol Venereol. 2019 Nov 12. doi: 10.1111/jdv.16065. [Epub ahead of print]

PMID:
31715046
3.

Corresponding anaplastic lymphoma kinase-tropomyosin 3 (ALK-TPM3) fusion in a patient with a primary cutaneous anaplastic large-cell lymphoma and a Spitz nevus.

Melchers RC, Willemze R, van Doorn R, Jansen PM, Cleven AHG, Solleveld N, Vermeer MH, Quint KD.

JAAD Case Rep. 2019 Oct 24;5(11):970-972. doi: 10.1016/j.jdcr.2019.09.021. eCollection 2019 Nov. No abstract available.

4.

Acetylcholine-producing T cells augment innate immune-driven colitis but are redundant in T cell-driven colitis.

Willemze RA, Brinkman DJ, Welting O, van Hamersveld PHP, Verseijden C, Luyer MD, Wildenberg ME, Seppen J, de Jonge WJ.

Am J Physiol Gastrointest Liver Physiol. 2019 Nov 1;317(5):G557-G568. doi: 10.1152/ajpgi.00067.2019. Epub 2019 Jul 19.

PMID:
31322912
5.

A rare case of cutaneous Epstein-Barr virus-negative intravascular cytotoxic T-cell lymphoma.

Melchers RC, Willemze R, Jansen PM, Daniëls LA, Vermeer MH, Quint KD.

JAAD Case Rep. 2019 Jun 13;5(6):548-551. doi: 10.1016/j.jdcr.2019.04.013. eCollection 2019 Jun. No abstract available.

6.

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.

Baron F, Efficace F, Cannella L, Willemze R, Vignetti M, Muus P, Marie JP, Ferrero D, Fazi P, La Sala E, Bourhis JH, Fabbiano F, Bosi A, Sborgia M, Martinelli G, Wittnebel S, Trisolini S, Petti MC, Halkes CJM, van der Velden WJFM, de Witte T, Amadori S, Zittoun RA, Suciu S.

Haematologica. 2019 May 16. pii: haematol.2019.221333. doi: 10.3324/haematol.2019.221333. [Epub ahead of print]

7.

Generalized Molluscum Contagiosum Successfully Treated with Interferon-Alpha in a Patient with Folliculotropic Mycosis Fungoides.

Melchers RC, Willemze R, Jansen PM, Vermaat JSP, Vermeer MH, Quint KD.

Case Rep Dermatol. 2019 Feb 26;11(1):52-56. doi: 10.1159/000497349. eCollection 2019 Jan-Apr.

8.

Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire.

Koning MT, Quinten E, Zoutman WH, Kiełbasa SM, Mei H, van Bergen CAM, Jansen P, Vergroesen RD, Willemze R, Vermeer MH, Tensen CP, Veelken H.

J Invest Dermatol. 2019 Oct;139(10):2195-2203. doi: 10.1016/j.jid.2019.04.005. Epub 2019 Apr 28.

PMID:
31042459
9.

The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.

Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES.

Blood. 2019 Apr 18;133(16):1703-1714. doi: 10.1182/blood-2018-11-881268. Epub 2019 Jan 11. Review. Erratum in: Blood. 2019 Sep 26;134(13):1112.

PMID:
30635287
10.

Loss of intestinal sympathetic innervation elicits an innate immune driven colitis.

Willemze RA, Welting O, van Hamersveld P, Verseijden C, Nijhuis LE, Hilbers FW, Meijer SL, Heesters BA, Folgering JHA, Darwinkel H, Blancou P, Vervoordeldonk MJ, Seppen J, Heinsbroek SEM, de Jonge WJ.

Mol Med. 2019 Jan 7;25(1):1. doi: 10.1186/s10020-018-0068-8.

11.

Ethnicity in mycosis fungoides: white patients present at an older age and with more advanced disease.

Scarisbrick JJ, Quaglino P, Prince HM, Kim YH, Willemze R; PROCLIPI investigators.

Br J Dermatol. 2019 May;180(5):1264-1265. doi: 10.1111/bjd.17602. Epub 2019 Jan 27. No abstract available.

PMID:
30604865
12.

Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype.

Baron F, Stevens-Kroef M, Kicinski M, Meloni G, Muus P, Marie JP, Halkes CJM, Thomas X, Vrhovac R, Albano F, Lefrère F Sr, Sica S, Mancini M, Venditti A, Hagemeijer A, Jansen JH, Amadori S, de Witte T, Willemze R, Suciu S.

Haematologica. 2019 Jun;104(6):1168-1175. doi: 10.3324/haematol.2018.204826. Epub 2018 Dec 6.

13.

Array-based CGH of primary cutaneous CD8+ aggressive EPIDERMO-tropic cytotoxic T-cell lymphoma.

Fanoni D, Corti L, Alberti-Violetti S, Tensen CP, Venegoni L, Vermeer M, Willemze R, Berti E.

Genes Chromosomes Cancer. 2018 Dec;57(12):622-629. doi: 10.1002/gcc.22673. Epub 2018 Oct 11.

PMID:
30307677
14.

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.

Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Guenova E, Child F, Whittaker S, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Koletsa T, Jonak C, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio A, Dummer R, Pimpinelli N, Grandi V, Beylot-Barry M, Pham-Ledard A, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Trautinger F, Latzka J, Yoo J, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen MD, Battistella M, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Vakeva L, Ranki A, Busschots AM, Hauben E, Bervoets A, Woei-A-Jin FJSH, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Arumainathan A, Azurdia R, Benstead K, Twigger R, Rieger K, Brown R, Sanches JA, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco FM, Querfeld C, Folkes A, Bur C, Klemke CD, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Willemze R.

Br J Dermatol. 2019 Aug;181(2):350-357. doi: 10.1111/bjd.17258. Epub 2018 Nov 25.

PMID:
30267549
15.

Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.

Deenen NJ, Koens L, Jaspars EH, Vermeer MH, Willemze R, de Rie MA, Bekkenk MW.

Br J Dermatol. 2019 Feb;180(2):411-412. doi: 10.1111/bjd.17252. Epub 2018 Oct 22. No abstract available.

PMID:
30259963
16.

Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.

Bastidas Torres AN, Cats D, Mei H, Szuhai K, Willemze R, Vermeer MH, Tensen CP.

Genes Chromosomes Cancer. 2018 Dec;57(12):653-664. doi: 10.1002/gcc.22679. Epub 2018 Oct 25.

17.

High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.

Schrader AMR, Jansen PM, Vermeer MH, Kleiverda JK, Vermaat JSP, Willemze R.

Am J Surg Pathol. 2018 Nov;42(11):1488-1494. doi: 10.1097/PAS.0000000000001132.

PMID:
30113335
18.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2019 Mar 1;30(3):494. doi: 10.1093/annonc/mdy207. No abstract available.

PMID:
29947731
19.

Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.

Baron F, Stevens-Kroef M, Kicinski M, Meloni G, Muus P, Marie JP, Halkes CJM, Thomas X, Vrhovac R, Specchia G, Lefrere F Sr, Sica S, Mancini M, Venditti A, Hagemeijer A, Becker H, Jansen JH, Amadori S, de Witte T, Willemze R, Suciu S.

Ann Hematol. 2018 Oct;97(10):1785-1795. doi: 10.1007/s00277-018-3396-4. Epub 2018 Jun 20.

20.

Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv30-iv40. doi: 10.1093/annonc/mdy133. No abstract available.

PMID:
29878045
21.

Mycosis fungoides variants-clinicopathologic features, differential diagnosis, and treatment.

Willemze R.

Semin Cutan Med Surg. 2018 Mar;37(1):11-17. doi: 10.12788/j.sder.2018.004. Review.

PMID:
29719015
22.

The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study.

Gru AA, Kim J, Pulitzer M, Guitart J, Battistella M, Wood GS, Cerroni L, Kempf W, Willemze R, Pawade J, Querfeld C, Schaffer A, Pincus L, Tetzlaff M, Duvic M, Scarisbrick J, Porcu P, Mangold AR, DiCaudo DJ, Shinohara M, Hong EK, Horton B, Kim YH.

Am J Surg Pathol. 2018 Jun;42(6):726-734. doi: 10.1097/PAS.0000000000001041.

PMID:
29543675
23.

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.

Schrader AMR, Jansen PM, Willemze R, Vermeer MH, Cleton-Jansen AM, Somers SF, Veelken H, van Eijk R, Kraan W, Kersten MJ, van den Brand M, Stevens WBC, de Jong D, Abdul Hamid M, Tanis BC, Posthuma EFM, Nijland M, Diepstra A, Pals ST, Cleven AHG, Vermaat JSP.

Blood. 2018 May 3;131(18):2086-2089. doi: 10.1182/blood-2017-12-822817. Epub 2018 Mar 7. No abstract available.

PMID:
29514783
24.

Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group.

Melchers RC, Willemze R, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Veraart JCJM, Vermeer MH, Quint KD.

Br J Dermatol. 2018 Sep;179(3):724-731. doi: 10.1111/bjd.16501. Epub 2018 Jun 21.

PMID:
29494757
25.

β-Blocker use is associated with a higher relapse risk of inflammatory bowel disease: a Dutch retrospective case-control study.

Willemze RA, Bakker T, Pippias M, Ponsioen CY, de Jonge WJ.

Eur J Gastroenterol Hepatol. 2018 Feb;30(2):161-166. doi: 10.1097/MEG.0000000000001016.

PMID:
29111997
26.

Folliculotropic mycosis fungoides presenting with a solitary lesion: Clinicopathological features and long-term follow-up data in a series of 9 cases.

van Santen S, Jansen PM, Vermeer MH, Willemze R.

J Cutan Pathol. 2018 Feb;45(2):122-128. doi: 10.1111/cup.13077. Epub 2017 Dec 11.

PMID:
29086994
27.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2017 Oct 1;28(10):2517-2525. doi: 10.1093/annonc/mdx352. Erratum in: Ann Oncol. 2019 Mar 1;30(3):494.

PMID:
28961843
28.

Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.

Melchers RC, Willemze R, Daniëls LA, Neelis KJ, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Velstra B, Veraart JCJM, Roach REJ, Vermeer MH, Quint KD.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1279-1285. doi: 10.1016/j.ijrobp.2017.08.010. Epub 2017 Aug 24.

PMID:
28958772
29.

Neuronal control of experimental colitis occurs via sympathetic intestinal innervation.

Willemze RA, Welting O, van Hamersveld HP, Meijer SL, Folgering JHA, Darwinkel H, Witherington J, Sridhar A, Vervoordeldonk MJ, Seppen J, de Jonge WJ.

Neurogastroenterol Motil. 2018 Mar;30(3). doi: 10.1111/nmo.13163. Epub 2017 Jul 26.

PMID:
28745812
30.

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R.

Eur J Cancer. 2017 May;77:57-74. doi: 10.1016/j.ejca.2017.02.027. Epub 2017 Mar 31. Review.

31.

Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group.

van Santen S, van Doorn R, Neelis KJ, Daniëls LA, Horváth B, Bruijn MS, Sanders CJG, van Rossum MM, de Haas ERM, Veraart JCJM, Bekkenk MW, Vermeer MH, Willemze R.

Br J Dermatol. 2017 Jul;177(1):223-228. doi: 10.1111/bjd.15355. Epub 2017 May 11.

PMID:
28132406
32.

Cutaneous lymphomas with a panniculitic presentation.

Willemze R.

Semin Diagn Pathol. 2017 Jan;34(1):36-43. doi: 10.1053/j.semdp.2016.11.009. Epub 2016 Nov 29. Review.

PMID:
27986433
33.

Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.

Boonk SE, Zoutman WH, Putter H, Ram-Wolff C, Felcht M, Klemke CD, Ranki A, Quaglino P, Whittaker S, Bagot M, Willemze R, Vermeer MH.

J Invest Dermatol. 2017 Mar;137(3):754-757. doi: 10.1016/j.jid.2016.10.025. Epub 2016 Oct 28. No abstract available.

34.

Acetylcholine-producing T cells in the intestine regulate antimicrobial peptide expression and microbial diversity.

Dhawan S, De Palma G, Willemze RA, Hilbers FW, Verseijden C, Luyer MD, Nuding S, Wehkamp J, Souwer Y, de Jong EC, Seppen J, van den Wijngaard RM, Wehner S, Verdu E, Bercik P, de Jonge WJ.

Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G920-G933. doi: 10.1152/ajpgi.00114.2016. Epub 2016 Aug 11.

35.

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial.

Selleslag D, Suciu S, Meloni G, Muus P, Halkes CJ, Venditti A, Ramadan SM, Pruijt H, Meert L, Vignetti M, Marie JP, Wittnebel S, de Witte T, Amadori S, Willemze R, Baron F.

Haematologica. 2017 Feb;102(2):e47-e51. doi: 10.3324/haematol.2016.153130. Epub 2016 Oct 27. No abstract available.

36.

p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern.

Genders RE, Beck S, Bouwes Bavinck JN, van den Munckhof HA, Kouwenhoven ST, de Koning MN, de Gruijl FR, Jenkins D, Willemze R, Quint KD.

J Cutan Pathol. 2017 Jan;44(1):28-33. doi: 10.1111/cup.12840. Epub 2016 Oct 25.

PMID:
27717097
37.

The clinical spectrum of mycosis fungoides in Tanzania, East Africa.

Grijsen ML, Mtayangulwa RG, Naafs B, Jansen P, Vermeer MH, Mavura D, Masenga EJ, Willemze R.

Br J Dermatol. 2017 Jun;176(6):1653-1656. doi: 10.1111/bjd.14963. Epub 2017 Mar 28. No abstract available.

PMID:
27529394
38.

Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.

Versluis J, In 't Hout FE, Devillier R, van Putten WL, Manz MG, Vekemans MC, Legdeur MC, Passweg JR, Maertens J, Kuball J, Biemond BJ, Valk PJ, van der Reijden BA, Meloni G, Schouten HC, Vellenga E, Pabst T, Willemze R, Löwenberg B, Ossenkoppele G, Baron F, Huls G, Cornelissen JJ.

Leukemia. 2017 Jan;31(1):26-33. doi: 10.1038/leu.2016.183. Epub 2016 Jun 24.

PMID:
27416910
39.

Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides.

van Santen S, Roach RE, van Doorn R, Horváth B, Bruijn MS, Sanders CJ, de Pooter JC, van Rossum MM, de Haas ER, Veraart JC, Bekkenk MW, Vermeer MH, Willemze R.

JAMA Dermatol. 2016 Sep 1;152(9):992-1000. doi: 10.1001/jamadermatol.2016.1597.

PMID:
27276223
40.

TOX expression in cutaneous B-cell lymphomas.

Schrader AM, Jansen PM, Willemze R.

Arch Dermatol Res. 2016 Aug;308(6):423-7. doi: 10.1007/s00403-016-1654-7. Epub 2016 May 14.

41.

No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course.

Schrader AM, Chung YY, Jansen PM, Szuhai K, Bastidas Torres AN, Tensen CP, Willemze R.

Blood. 2016 Jul 7;128(1):141-3. doi: 10.1182/blood-2016-02-694455. Epub 2016 May 4. No abstract available.

PMID:
27146432
42.

Epigenomic Analysis of Sézary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies Diagnostic Markers.

van Doorn R, Slieker RC, Boonk SE, Zoutman WH, Goeman JJ, Bagot M, Michel L, Tensen CP, Willemze R, Heijmans BT, Vermeer MH.

J Invest Dermatol. 2016 Sep;136(9):1876-1884. doi: 10.1016/j.jid.2016.03.042. Epub 2016 Apr 23. Review.

43.

TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+)  CD8(-) phenotype.

Schrader AM, Jansen PM, Willemze R.

Br J Dermatol. 2016 Aug;175(2):382-6. doi: 10.1111/bjd.14508. Epub 2016 Jun 29.

PMID:
26931394
44.

Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients.

Boonk SE, Zoutman WH, Marie-Cardine A, van der Fits L, Out-Luiting JJ, Mitchell TJ, Tosi I, Morris SL, Moriarty B, Booken N, Felcht M, Quaglino P, Ponti R, Barberio E, Ram-Wolff C, Jäntti K, Ranki A, Bernengo MG, Klemke CD, Bensussan A, Michel L, Whittaker S, Bagot M, Tensen CP, Willemze R, Vermeer MH.

J Invest Dermatol. 2016 Jul;136(7):1364-1372. doi: 10.1016/j.jid.2016.01.038. Epub 2016 Feb 28.

45.

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial.

Amadori S, Suciu S, Selleslag D, Aversa F, Gaidano G, Musso M, Annino L, Venditti A, Voso MT, Mazzone C, Magro D, De Fabritiis P, Muus P, Alimena G, Mancini M, Hagemeijer A, Paoloni F, Vignetti M, Fazi P, Meert L, Ramadan SM, Willemze R, de Witte T, Baron F.

J Clin Oncol. 2016 Mar 20;34(9):972-9. doi: 10.1200/JCO.2015.64.0060. Epub 2016 Jan 25.

46.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodríguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH.

J Clin Oncol. 2015 Nov 10;33(32):3766-73. doi: 10.1200/JCO.2015.61.7142. Epub 2015 Oct 5.

47.

Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).

de Witte T, Suciu S, Meert L, Halkes C, Selleslag D, Bron D, Amadori S, Willemze R, Muus P, Baron F.

Ann Hematol. 2015 Dec;94(12):1981-9. doi: 10.1007/s00277-015-2486-9. Epub 2015 Sep 26.

48.

Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group.

Bruijn MS, Horváth B, van Voorst Vader PC, Willemze R, Vermeer MH.

Br J Dermatol. 2015 Nov;173(5):1319-22. doi: 10.1111/bjd.13920. Epub 2015 Oct 8. No abstract available.

PMID:
25998985
49.

Neural reflex pathways in intestinal inflammation: hypotheses to viable therapy.

Willemze RA, Luyer MD, Buurman WA, de Jonge WJ.

Nat Rev Gastroenterol Hepatol. 2015 Jun;12(6):353-62. doi: 10.1038/nrgastro.2015.56. Epub 2015 May 12. Review.

PMID:
25963513
50.

Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.

Klemke CD, Booken N, Weiss C, Nicolay JP, Goerdt S, Felcht M, Géraud C, Kempf W, Assaf C, Ortonne N, Battistella M, Bagot M, Knobler R, Quaglino P, Arheiliger B, Santucci M, Jansen P, Vermeer MH, Willemze R.

Br J Dermatol. 2015 Jul;173(1):93-105. doi: 10.1111/bjd.13832. Epub 2015 Jun 23.

Supplemental Content

Loading ...
Support Center